Single-dose pharmacokinetic properties of esomeprazole in children aged 1 - 11 years with endoscopically proven GERD: A randomized, open-label study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 52, Issue 11, 2014, Pages 965-972

  Youssef, Nader N ^a,f   Tron, Eduardo ^b,g   Tolia, Vasundhara ^c,h   Hamer Maansson, Jennifer E ^d   Lundborg, Per ^e   Illueca, Marta ^d  

^a NPS Pharmaceuticals   (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

^c PROVIDENCE HOSPITAL   (United States)

^d ASTRAZENECA   (United Kingdom)

^e ASTRAZENECA R AND D   (Sweden)

^f Atlantic Health   (United States)

^g CHILDREN S HOSPITAL OF BUFFALO   (United States)

^h MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

AUC pharmacokinetics; Dosing; Esomeprazole; GERD; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; ANTIULCER AGENT;

AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CLEARANCE; DRUG TOLERABILITY; EAR INFECTION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; OPEN STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE DRUG DOSE; SINUSITIS; TIME TO MAXIMUM PLASMA CONCENTRATION; UPPER RESPIRATORY TRACT INFECTION; VOLUME OF DISTRIBUTION; INFANT;

ANTI-ULCER AGENTS; CHILD; CHILD, PRESCHOOL; ESOMEPRAZOLE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT; MALE;

EID: 84920138954     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201971     Document Type: Article

References (17)

1. Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, Sondheimer J, Staiano A, Thomson M, Veereman-Wauters G, Wenzl TG; North American Society for Pediatric Gastroenterology Hepatology and Nutrition; European Society for Pediatric Gastroenterology Hepatology and Nutrition. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009; 49: 498-547. PubMed
2. Nelson SP, Chen EH, Syniar GM, Christoffel KK; Pediatric Practice Research Group. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Arch Pediatr Adolesc Med. 2000; 154: 150-154. Cross-Ref PubMed
3. Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, Johnson SP, Allen J, Brill JV; American Gastroenterological Association. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008; 135: 1383-1391., e1-e5. CrossRef PubMed
4. Gilger MA, Tolia V, Vandenplas Y, Youssef NN, Traxler B, Illueca M. Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2008; 46: 524-533. CrossRef PubMed
5. Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr. 2007; 44: 41-44. CrossRef PubMed
6. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009; 154: 514-520., e4. CrossRef PubMed
7. Tolia V. Esomeprazole use in pediatrics. Ped Health. 2008; 2: 687-696. CrossRef
8. Kothari S, Nelson SP, Wu EQ, Beaulieu N, McHale JM, Dabbous OH. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors. Curr Med Res Opin. 2009; 25: 2703-2709. PubMed
9. U.S. Department of Health & Human Services. U.S. Food and Drug Administration Web site. Available at http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ DevelopmentResources/ ucm049867.htm.
10. Omari T, Davidson G, Bondarov P, Nauclér E, Nilsson C, Lundborg P. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007; 45: 530-537. CrossRef PubMed
11. Li J, Zhao J, Hamer-Maansson JE, Andersson T, Fulmer R, Illueca M, Lundborg P. Pharmacokinetic properties of esomeprazole in adolescent patients aged 12 to 17 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study. Clin Ther. 2006; 28: 419-427. CrossRef PubMed
12. Zhao J, Li J, Hamer-Maansson JE, Andersson T, Fulmer R, Illueca M, Lundborg P. Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study. Clin Ther. 2006; 28: 1868-1876. CrossRef PubMed
13. Andersson T, Hassan-Alin M, Hasselgren G, Röhss K, Weidolf L. Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole. Clin Pharmacokinet. 2001; 40: 411-426. CrossRef PubMed
14. Hassan-Alin M, Andersson T, Bredberg E, Röhss K. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. Eur J Clin Pharmacol. 2000; 56: 665-670. CrossRef PubMed
15. Andersson T, Hassall E, Lundborg P, Shepherd R, Radke M, Marcon M, Dalväg A, Martin S, Behrens R, Koletzko S, Becker M, Drouin E, Göthberg G; International Pediatric Omeprazole Pharmacokinetic Group. Pharmacokinetics of orally administered omeprazole in children. Am J Gastroenterol. 2000; 95: 3101-3106. CrossRef PubMed
16. Hussein Z, Granneman GR, Mukherjee D, Samara E, Hogan DL, Koss MA, Isenberg JI. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole. Br J Clin Pharmacol. 1993; 36: 391-398. CrossRef PubMed
17. Illueca M, Wernersson B, Henderson C, Lundborg P. Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis. J Pediatr Gastroenterol Nutr. 2010; 51: 733-740. CrossRef PubMed